Allen Lee Cohn
Allen Lee Cohn publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Lung Cancer Treatments and Mutations.
- World rank
- #115,382 of 7,710,434 ranked researchers
- Rank in United States
- #43,990 of 1,627,098
- Works
- 233
- Citations
- 16k
- Citations per work
- 67.2
What does Allen Lee Cohn research?
Allen Lee Cohn's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15466.2%
- Medicine15466.2%
- Everything else5021.3%
- Life Sciences2912.5%
- 1Oncology40% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Molecular Biology6% of their works
- 4Surgery6% of their works
- 5Cancer Research6% of their works
- 6Hepatology4% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Hepatocellular Carcinoma Treatment and Prognosis
- Pancreatic and Hepatic Oncology Research
Which keywords describe Allen Lee Cohn's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Targeted Therapy, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Clinical Practice Guidelines and Tumor Microenvironment.
- Surgical Complications
- Liver Cancer
- PD-1 and PD-L1
- Mutational Signatures
- Gastric Cancer
- EGFR Mutations
- Tumor Microenvironment
- Taxanes
- Targeted Therapy
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Chemotherapy-Induced Peripheral Neuropathy
- Clinical Practice Guidelines
- ALK Inhibitors
- Endoscopic Resection
- Cancer Genomics
- Immune Checkpoint Blockade
- Hepatocellular Carcinoma
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy1443 topics
- Cetuximab931 topic
- KRAS Mutations931 topic
- Targeted Therapy662 topics
- Chemotherapy-Induced Peripheral Neuropathy551 topic
- Taxanes551 topic
- Clinical Practice Guidelines522 topics
- Tumor Microenvironment482 topics
- ALK Inhibitors391 topic
- EGFR Mutations391 topic
- Endoscopic Resection291 topic
- Gastric Cancer291 topic
- Cancer Genomics271 topic
- Mutational Signatures271 topic
- Immune Checkpoint Blockade261 topic
- PD-1 and PD-L1261 topic
- Hepatocellular Carcinoma231 topic
- Liver Cancer231 topic
- Pancreatic Cancer221 topic
- Surgical Complications221 topic
Where does Allen Lee Cohn work?
Allen Lee Cohn's main affiliation in the publication record is Rocky Mountain Cancer Centers, United States.
How many publications and citations does Allen Lee Cohn have?
OpenAlex counts 233 works and 15,653 citations for Allen Lee Cohn, an h-index of 49, ranking #115,382 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Allen Lee Cohn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.